How glyphosate exposure may affect metabolism and gut bacteria

The Ability of Glyphosate to Impair Metabolic Homeostasis Via the Gut Microbiome and Metabolites

['FUNDING_R01'] · UNIVERSITY OF MINNESOTA · NIH-11329006

This project tests whether exposure to the common herbicide glyphosate changes gut bacteria and bile acids in ways that could raise adult risk of obesity and type 2 diabetes.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorUNIVERSITY OF MINNESOTA (nih funded)
Locations1 site (MINNEAPOLIS, UNITED STATES)
Trial IDNIH-11329006 on ClinicalTrials.gov

What this research studies

Researchers will study how glyphosate affects the gut microbiome and the bile acid signaling that helps control energy and glucose balance. The team will use laboratory models and molecular analyses to track changes in bacterial communities and metabolite profiles tied to Farnesoid X receptor (FXR) signaling. Measured outcomes will include shifts in bile acids, microbiome composition, and metabolic markers related to weight and glucose regulation. The work aims to connect environmental herbicide exposure to mechanisms that could contribute to obesity and adult-onset diabetes.

Who could benefit from this research

Good fit: Adults concerned about overweight, obesity, or type 2 diabetes—especially those with potential agricultural or environmental glyphosate exposure—would be the most relevant group for these findings.

Not a fit: People without glyphosate exposure or whose metabolic problems are clearly caused by other factors (for example specific genetic disorders) may not directly benefit from this research.

Why it matters

Potential benefit: If findings link glyphosate to harmful changes in gut bacteria and bile acid signaling, the work could point to ways to reduce exposure or target the microbiome to help prevent or treat obesity and type 2 diabetes.

How similar studies have performed: Prior studies have linked pesticides and microbiome changes to metabolic effects, but direct evidence tying glyphosate to obesity or diabetes in humans is limited and this question remains largely untested.

Where this research is happening

MINNEAPOLIS, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Adult-Onset Diabetes Mellitus, Cancers

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.